Newsbenzinga
AstraZeneca Turns to AI to Crack Tough Heart and Liver Diseases in Billion-Dollar Deal
· Published
Article summary
AstraZeneca pairs with Insitro on a $1.5B AI collaboration to advance drug targets for MASH and heart conditions.
An excerpt from the original article.
Comments —
Loading comments…